5-HT1D
9 drugs CNS
2
approved indications
9
Approved Drugs
8
Companies
2
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (8 companies)
✓ All 9 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (2 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
TONIX MEDS 2 drugs
LANNETT CO INC 1 drug
GSK 1 drug
By Therapeutic Area
CNS 9 drugs
Drugs by Company PRO
TONIX MEDS 2 drugs
LANNETT CO INC 1 drug
GSK 1 drug
GLENMARK PHARMS LTD 1 drug
Sun Pharma 1 drug
ENDO OPERATIONS 1 drug
CHARTWELL RX 1 drug
CURRAX 1 drug
By Therapeutic Area
CNS 9 drugs
SUMATRIPTAN, IMITREX STATDOSE, FROVATRIPTAN SUCCINATE, SUMATRIPTAN AND NAPROXEN SODIUM +5 more
Indications Treated
MigraineCluster Headache
All Drugs Targeting 5-HT1D
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| SUMATRIPTAN | LANNETT CO INC | 2016 | 2 | CNS |
| IMITREX STATDOSE | GSK | 1992 | 2 | CNS |
| FROVATRIPTAN SUCCINATE | GLENMARK PHARMS LTD | 2014 | 2 | CNS |
| SUMATRIPTAN AND NAPROXEN SODIUM | Sun Pharma | 2018 | 2 | CNS |
| FROVA | ENDO OPERATIONS | 2001 | 2 | CNS |
| RIZATRIPTAN BENZOATE | CHARTWELL RX | 2012 | 1 | CNS |
| ZEMBRACE SYMTOUCH | TONIX MEDS | 2016 | 1 | CNS |
| TOSYMRA | TONIX MEDS | 2019 | 1 | CNS |
| ONZETRA XSAIL | CURRAX | 2016 | 1 | CNS |